Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDUniverse Pharmaceuticals INC Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $1.58 | $1.58 | $1.58 |
| Q2 2024 | 1 | $1.34 | $1.34 | $1.34 |
| Q3 2024 | 1 | $1.54 | $1.54 | $1.54 |
Universe Pharmaceuticals INC Earnings Date And Information
Universe Pharmaceuticals INC last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 12.88 M for the quarter and had revenue of 32.31 M for the year. Universe Pharmaceuticals INC has generated $-2 earnings per share over the last year ($-1.7 diluted earnings per share) and currently has a price-to-earnings ratio of -0.12. Universe Pharmaceuticals INC has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 30th, 2024 based on prior year's report dates.
Universe Pharmaceuticals INC Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/20/2024 | Q2 2024 | -$3.59 | $12.88 M | $12.88 M | ||
| 01/30/2024 | Q4 2023 | -$1.50 | $13.84 M | |||
| 08/31/2023 | Q2 2023 | -$0.20 | $18.47 M | |||
| 02/10/2023 | Q4 2022 | -$2.89 | $15.94 M | |||
| 01/31/2022 | Q2 2022 | $0.48 | $24.20 M | |||
| 01/31/2022 | Q4 2021 | $1.15 | $23.69 M | |||
| 03/29/2021 | Q2 2021 | $1.97 | $24.29 M | |||
| 09/29/2020 | Q4 2020 | $0.09 | $7.68 M | |||
| 06/29/2020 | Q3 2020 | $0.09 | $7.68 M | |||
| 03/30/2020 | Q2 2020 | $0.09 | $7.68 M | |||
| 01/30/2020 | Q1 2020 | $0.09 | $7.68 M | |||
| 09/29/2019 | Q4 2019 | $0.09 | $8.31 M | |||
| 06/29/2019 | Q3 2019 | $0.09 | $8.31 M | |||
| 03/30/2019 | Q2 2019 | $0.09 | $8.31 M | |||
| 09/29/2018 | Q4 2018 | $0.09 | $7.13 M | |||
| 06/29/2018 | Q3 2018 | $0.09 | $7.13 M | |||
| 03/30/2018 | Q2 2018 | $0.09 | $7.13 M |
Universe Pharmaceuticals INC Earnings: FAQ's
When is Universe Pharmaceuticals INC's earnings date?
Universe Pharmaceuticals INC has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 30th, 2024 based off last year's report dates.
How can I listen to Universe Pharmaceuticals INC's earnings conference
call?
The conference call for Universe Pharmaceuticals INC's latest earnings report can be listened to online.
How can I read Universe Pharmaceuticals INC's conference call transcript?
The conference call transcript for Universe Pharmaceuticals INC's latest earnings report can be read online.
How much revenue does Universe Pharmaceuticals INC generate each year?
Universe Pharmaceuticals INC (:UPC) has a recorded annual revenue of $32.31 M.
How much profit does Universe Pharmaceuticals INC generate each year?
Universe Pharmaceuticals INC (:UPC) has a recorded net income of $32.31 M. Universe Pharmaceuticals INC has generated $-1.7 earnings per share over the last four quarters.
What is Universe Pharmaceuticals INC's price-to-earnings ratio?
Universe Pharmaceuticals INC (:UPC) has a price-to-earnings ratio of -0.12 and price/earnings-to-growth ratio is -0.